What's in Premier Specialists, Australia's pipeline?

Premier Specialists, Australia has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Premier Specialists, Australia's portfolio?

Top competitors by shared drug class: Actavis Inc., Army Medical University, China, Bausch Health Americas, Inc., Center for Sight Las Vegas, Centro Dermatológico Dr. Ladislao de la Pascua.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/premier-specialists-australia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Premier Specialists, Australia — Portfolio Competitive Intelligence Brief

Premier Specialists, Australia pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
isotretinoin (Roaccutane)	isotretinoin (Roaccutane)	marketed	Retinoid	Retinoid acid receptors (RAR and RXR)	Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Army Medical University, China · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
Center for Sight Las Vegas · 1 shared drug class
Centro Dermatológico Dr. Ladislao de la Pascua · 1 shared drug class
Cipher Pharmaceuticals Inc. · 1 shared drug class
Dr. Emmy Graber · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Premier Specialists, Australia:

Cite this brief

Drug Landscape (2026). Premier Specialists, Australia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/premier-specialists-australia. Accessed 2026-05-16.